Cargando…

Efficacy of erlotinib as neoadjuvant regimen in EGFR-mutant locally advanced non-small cell lung cancer patients

BACKGROUND: The optimal neoadjuvant regimen for locally advanced resectable non-small cell lung cancer (NSCLC) remains controversial. EGFR inhibitors have significantly improved survival in patients with EGFR-mutant advanced NSCLC. However, their efficacy in neoadjuvant settings, particularly for tr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Liwen, Lou, Yuqing, Bai, Hao, Li, Rong, Xia, Jinjing, Fang, Wentao, Zhang, Jie, Han-Zhang, Han, Lizaso, Analyn, Li, Bing, Gu, Aiqin, Han, Baohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Prospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7607055/ https://www.ncbi.nlm.nih.gov/pubmed/31885349 http://dx.doi.org/10.1177/0300060519887275

Ejemplares similares

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study
por: Xiong, Liwen, et al.
Publicado: (2018)

Mimicking the BIM BH3 domain overcomes resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant non-small cell lung cancer
por: Xia, Jinjing, et al.
Publicado: (2017)

Rechallenge with erlotinib in osimertinib-resistant lung adenocarcinoma mediated by driver gene loss: a case report
por: Liu, Lingli, et al.
Publicado: (2020)

The Journey of an EGFR-Mutant Lung Adenocarcinoma through Erlotinib, Osimertinib and ABCP Immunotherapy Regimens: Sensitivity and Resistance
por: Kibirova, Albina, et al.
Publicado: (2019)

The effectiveness of EGFR-TKIs against brain metastases in EGFR mutation-positive non-small-cell lung cancer
por: Bai, Hao, et al.
Publicado: (2017)

Akt kinase LANCL2 functions as a key driver in EGFR-mutant lung adenocarcinoma tumorigenesis
por: Lou, Yuqing, et al.
Publicado: (2021)

The clinicopathological and molecular characteristics of resected EGFR‐mutant lung adenocarcinoma
por: Zhou, Wensheng, et al.
Publicado: (2022)

HCC-derived EGFR mutants are functioning, EGF-dependent, and erlotinib-resistant
por: Sueangoen, Natthaporn, et al.
Publicado: (2020)

The association between BRAF mutation class and clinical features in BRAF-mutant Chinese non-small cell lung cancer patients
por: Lin, Quan, et al.
Publicado: (2019)

Clinical and molecular feature-based nomogram model for predicting benefit from bevacizumab combined with first-generation EGFR-tyrosine kinase inhibitor (TKI) in EGFR-mutant advanced NSCLC
por: Zhang, Yongchang, et al.
Publicado: (2021)

Bevacizumab plus erlotinib versus erlotinib alone for advanced EGFR-mutant non-small cell lung cancer: a meta-analysis of randomized clinical trials
por: Li, Ruijian, et al.
Publicado: (2023)

Combination of pegylated liposomal doxorubicin and docetaxel as neoadjuvant therapy for breast cancer with axillary lymph node metastasis
por: Wang, Li, et al.
Publicado: (2020)

Neoadjuvant chemoradiotherapy plus surgery in the treatment of potentially resectable thoracic esophageal squamous cell carcinoma
por: Yan, Mao-Hui, et al.
Publicado: (2020)

Addition of castor oil as a booster in colon capsule regimens significantly improves completion rates and polyp detection
por: Semenov, Serhiy, et al.
Publicado: (2021)

NF-κB-driven improvement of EHD1 contributes to erlotinib resistance in EGFR-mutant lung cancers
por: Wang, Xiaoyuan, et al.
Publicado: (2018)

Desimplification to multi-tablet antiretroviral regimens in human immunodeficiency virus-type 1 infected adults: A cohort study
por: Rossi, Maria C, et al.
Publicado: (2019)

Application of pulse index continuous cardiac output system in elderly patients with acute myocardial infarction complicated by cardiogenic shock: A prospective randomized study
por: Zhang, Yuan-Bo, et al.
Publicado: (2019)

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison
por: Chen, Chun-Ting, et al.
Publicado: (2022)

Transformation of NSCLC to SCLC after 1st- and 3rd-generation EGFR-TKI resistance and response to EP regimen and erlotinib: 2 CARE-compliant case reports
por: Lai, Lin, et al.
Publicado: (2021)

Neoadjuvant EGFR-TKI Therapy for EGFR-Mutant NSCLC: A Systematic Review and Pooled Analysis of Five Prospective Clinical Trials
por: Sun, Li, et al.
Publicado: (2021)

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
por: Yang, Zhengyu, et al.
Publicado: (2021)

Intermittent high-dose treatment with erlotinib enhances therapeutic efficacy in EGFR-mutant lung cancer
por: Schöttle, Jakob, et al.
Publicado: (2015)

MET amplification results in heterogeneous responses to osimertinib in EGFR‐mutant lung cancer treated with erlotinib
por: Nishiyama, Akihiro, et al.
Publicado: (2020)

The EGFR tyrosine kinase inhibitors as second-line therapy for EGFR wild-type non-small-cell lung cancer: a real-world study in People’s Republic of China
por: Xu, Jianlin, et al.
Publicado: (2016)

Back to the Future: Moving Beyond “Mesenchymal Stem Cells”
por: Bianco, Paolo
Publicado: (2011)

Niche Inheritance: A Cooperative Pathway to Enhance Cancer Cell Fitness Through Ecosystem Engineering
por: Yang, Kimberline R, et al.
Publicado: (2014)

Training by Publication: Can Journal be mentors
por: Shyam, Ashok
Publicado: (2016)

Sparse sampling: theory, methods and an application in neuroscience
por: Oñativia, Jon, et al.
Publicado: (2014)

Thinking in circuits: toward neurobiological explanation in cognitive neuroscience
por: Pulvermüller, Friedemann, et al.
Publicado: (2014)

A computational theory of visual receptive fields
por: Lindeberg, Tony
Publicado: (2013)

Spatio‐Temporal Parameters of Endosomal Signaling in Cancer: Implications for New Treatment Options
por: Stasyk, Taras, et al.
Publicado: (2015)

Internally coupled ears in living mammals
por: Mason, Matthew J.
Publicado: (2016)

RBM10: Harmful or helpful‐many factors to consider
por: Loiselle, Julie J., et al.
Publicado: (2018)

Therapeutic Potential of Matrix Metalloproteinase Inhibition in Breast Cancer
por: Radisky, Evette S., et al.
Publicado: (2017)

Ergodicity and parameter estimates in auditory neural circuits
por: Toth, Peter G., et al.
Publicado: (2017)

Winnerless competition in clustered balanced networks: inhibitory assemblies do the trick
por: Rost, Thomas, et al.
Publicado: (2017)

Methods for identification of spike patterns in massively parallel spike trains
por: Quaglio, Pietro, et al.
Publicado: (2018)

A theory of consciousness: computation, algorithm, and neurobiological realization
por: van Hateren, J. H.
Publicado: (2019)

Mechanical aspects of the semicircular ducts in the vestibular system
por: Muller, Mees
Publicado: (2020)

On the progress of 3D-printed hydrogels for tissue engineering
por: Advincula, Rigoberto C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a3pnj4lauhic9k2n87ol2s05n8